Abstract: The invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R1 to R7, A, Y and L are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Abstract: A computerized system for associating RF signals, the system including at least one sensor configured to sense a plurality of RF signals at at least a plurality of points in time and a computerized associator receiving outputs from the at least one sensor and providing an output which associates at least some of the plurality of RF signals with at least one unique multiple RF signal-based identifier.

Abstract: The present invention provides a method for operation of an offline uninterrupted power supplyfor providing power to a load in case of failure of a power source, the uninterrupted power supply comprising at least one disconnect switch, which is arranged between the power source and the load, at least one energy storage, at least one power converter, which is arranged between the at least one energy storage and the load at a load side of the disconnect switch, and a control device for controlling the at least one power converter to provide power from the at least one energy storage to the load in case of failure of the power source, comprising the steps of identifying a power quality event, differentiating the identified power quality events to separate load side events from power supply side quality events, and upon identification of a power supply side power quality event from an identified power quality event, providing power from the at least one energy storage to the load.

Abstract: Disclosed are novel substituted 2H-isoquinolin-1-one and 3H-quinazolin-4-one derivatives useful as inhibitors of Rho kinase and for treating a variety of diseases and disorders that are mediated or sustained through the activity of Rho kinase, including cardiovascular diseases, pharmaceutical compositions comprising such compounds, methods for using such compounds and processes for making such compounds.

Abstract: A system and method for testing a control system is disclosed. The control system includes a field device located in one area and a controller located in a different area. A mobile application running on a mobile computing device is used by a technician to test the control system. Because both the mobile computing device and the controller are coupled to a cloud computing system, the technician may interface with the controller while located at the field device. This remote access to the controller allows a single technician to test the control system by interfacing with the controller and the field device simultaneously. In addition, the mobile application may retrieve data from the cloud computing system to facilitate testing and may transmit test results to the cloud for storage. Others having access to the stored results may view the progress and results of the testing.

Abstract: The present invention provides bioactive serum fractions and bioactive extracts derived from an Achachairu (Garcinia humilis) plant. The bioactive serum fractions and bioactive extracts are free of or substantially free of benzophenone and/or free of or substantially free of proteins. The present invention also provides products comprising the bioactive serum fractions and/or bioactive extracts. The present invention further provides methods of making the bioactive serum fractions and/or bioactive extracts.

Abstract: A method of calibrating a bore gauge comprises inserting two or more radially extendable elements of a bore gauge into a selected calibrated setting bore or groove in a setting plate comprising a plurality of calibrated setting bores or grooves, each calibrated setting bore or groove of the plurality having a different calibrated nominal diameter. A micrometer of the bore gauge is adjusted so as to cause a measured diameter of the selected calibrated setting bore or groove to match a specified nominal diameter of the selected calibrated setting bore or groove. A setting plate for calibrating a bore gauge includes a plurality of calibrated setting bores or grooves, each calibrated setting bore or groove of the plurality having a different calibrated nominal diameter.

Abstract: The present invention encompasses compounds of formula (I) wherein the variables are defined herein which are suitable for the modulation of ROR? and the treatment of diseases related to the modulation of ROR?. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

Abstract: Disclosed are cartridge components, cartridges, systems, and methods for isolating analytes from biological samples. In various aspects, the cartridge components, cartridges, systems, and methods may allow for a rapid procedure that requires a minimal amount of material from complex fluids.

Abstract: A turbine engine temperature management system includes a turbine engine having a first turbine and a second turbine, a temperature sensor positioned between the first turbine and the second turbine and configured to sense a turbine engine temperature between the first turbine and the second turbine, a modulating fuel flow valve configured to control a fuel flow to the turbine engine, and a temperature controller configured to limit fuel flow to the turbine engine.

Abstract: The invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R1 to R7, A, Y and L are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Abstract: The invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R1 to R7, A, Y and L are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Abstract: The present invention is concerned with pre-magnetizing a Modular Multilevel power Converters connected transformer in order to moderate inrush currents upon connecting the transformer to an electric grid. The invention takes advantage of the high amount of stored energy in MMC converters as compared to other converter types. This stored energy is used to pre-magnetize the converter-connected transformer, therefore no additional or dedicated pre-magnetizing hardware is required in addition to the charging hardware provided to charge the converter capacitors. As the transformer pre-magnetizing takes place subsequent to the converter charging, the converter charging circuit is not used to, and therefore does not need to be designed to, directly magnetize the transformer.

Abstract: A method is provided for safely executing dynamically generated code to avoid the possibility of an attack in unprotected memory space. Upon ascertaining that dynamically generated code is to be executed, a processing circuit and/or operating system kernel restrict the dynamically generated code to use a first memory region within an unprotected memory space, where the first memory region is distinct (e.g., reserved) from other memory regions used by other processes executed by the processing circuit. A first processing stack is maintained for the dynamically generated code within the first memory region. This first processing stack is separate from a general processing stack used by other processes executed by the processing circuit. A stack pointer is switched/pointed to the first processing stack when the dynamically generated code is executed and the stack pointer is switched/pointed to the general processing stack when the dynamically generated code ends.

Abstract: Disclosed are cartridge components, cartridges, systems, and methods for isolating analytes from biological samples. In various aspects, the cartridge components, cartridges, systems, and methods may allow for a rapid procedure that requires a minimal amount of material from complex fluids.

Abstract: The present invention relates to bioactive compositions (including, for example, bioactive serum fractions and bioactive extracts) derived from ginseng (Panax spp.) fresh whole plant, a particular part of the plant (e.g., rhizome, roots, leaves, stems, flowers, fruit) or any combination of these plant parts. The bioactive serum fractions and bioactive extracts are free of or substantially free of pulegone and/or free of or substantially free of proteins. The present invention also provides products comprising the bioactive serum fractions and/or bioactive extracts. The present invention further provides methods of making and using the bioactive serum fractions and/or bioactive extracts. Further, the bioactive serum fractions and bioactive extracts have anti-inflammatory and/or anti-irritant and/or anti-aging activities.

Abstract: The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of ROR? and the treatment of diseases related to the modulation of ROR?. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

Abstract: Disclosed are novel substituted 2H-isoquinolin-1-one and 3H-quinazolin-4-one derivatives useful as inhibitors of Rho kinase and for treating a variety of diseases and disorders that are mediated or sustained through the activity of Rho kinase, including cardiovascular diseases, pharmaceutical compositions comprising such compounds, methods for using such compounds and processes for making such compounds.

Abstract: Systems, devices, media, methods, and kits are disclosed to integrate and exchange information of analyte analysis kits. Analyte analysis can be performed and presented using in association with advertising or questions.

Abstract: The present invention encompasses compounds of formula (I) wherein the variables are defined herein which are suitable for the modulation of ROR? and the treatment of diseases related to the modulation of ROR?. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.